Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Thursday, July 18, 2024 | Back issues
Courthouse News Service Courthouse News Service

Merck Pays $615 Million in Vioxx Settlement

JEFFERSON CITY, Mo. (CN) - Merck Sharp & Dohme will pay $615 million to 43 states and the federal government to settle claims about its marketing of Vioxx.

Merck pushed Vioxx as a treatment for rheumatoid arthritis before the Food and Drug Administration approved it for that, and misled consumers about the cardiovascular safety of Vioxx, which Merck pulled from the market in 2004.

Merck cited increased "cardiovascular events" among Vioxx-users in pulling the drug from the shelves.

Merck pleaded guilty to violating the Food, Drug and Cosmetic Act and will pay a criminal fine and forfeiture of more than $300 million.

Missouri will get more than $13.8 million from the settlement, Missouri Attorney General Chris Koster said.

Follow @@joeharris_stl
Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.